Trademarkia Logo

Canada

C$
ETHERNA
FORMALIZED

on 21 Jun 2023

Last Applicant/ Owned by

ETHERNA IMMUNOTHERAPIES NV

Galileilaan 19Niel, 2845

BE

Serial Number

2264972 filed on 21st Jun 2023

Correspondent Address

MOFFAT & CO.

P.O. Box 2088, Station DOttawa

ONTARIO

CA

K1P5W3

ETHERNA

Trademark usage description

biological preparations for boosting cells in the immune system for improved therapies; biological preparations, namely, a mrna-based composition for Read More

Classification Information


Class [001]
Biological preparations for boosting cells in the immune system for improved therapies; biological preparations, namely, a mRNA-based composition for enhancing immunities; biological preparations in the nature of genetically modified cells and vectors for scientific and research purposes; biological and chemical reagents including complexes of these molecules for research and for clinical and industrial use


Classification kind code

12

Class [005]
Vaccines; vaccine adjuvants; medical, biological, and pharmaceutical preparations for medical use, namely, preparations containing messenger RNA for preventing and treating viruses, medical disorders, and diseases; mRNA-based therapeutics and therapeutic agents for in prevention and treatment of viruses, medical disorders, and diseases; lipid nanoparticles for pharmaceutical, medical or diagnostic purposes; drug carriers for medical use, namely, lipid nanoparticles for delivering drugs; lipid nanoparticles for drug delivery sold as an integral component of drugs; pharmaceutical preparations, namely, messenger RNA and delivery agents comprised of lipid nanoparticle carriers and polymers for the delivery of mRNA to human cells


Classification kind code

12

Class [040]
Custom manufacture of pharmaceutical and medical preparations; custom manufacture of mRNA molecules; custom manufacture of mRNA molecules formulated in lipid nanoparticles; custom manufacture of mRNA for use in vaccines, cell therapy, gene editing, protein replacement, and antibodies; provision of information, advice and consultancy services relating to all of the aforesaid


Classification kind code

12

Class [042]
Scientific research and development; pharmaceutical research and development services; medical research and development services; scientific, pharmaceutical, and medical research and development in the field of mRNA therapeutics; scientific, pharmaceutical, and medical research and development in the field of proprietary lipids and lipid nanoparticle formulations for the delivery of mRNA therapeutics for the treatment of various medical disorders, cancer, and infectious diseases


Classification kind code

12

Mark Details


Serial Number

2264972

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 287
on 6th Jul 2023
Pre-Assessment Letter Sent
Submitted for opposition 30
on 21st Jun 2023
Filed
Submitted for opposition 1
on 21st Jun 2023
Created
Submitted for opposition 31
on 21st Jun 2023
Formalized